Salmonella aortitis without surgery or fluoroquinolones: Complete resolution with sequential antibiotic therapy
4 affiliations
- 1Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
- 2Department of Radiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
- 3Department of Vascular Surgery, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
- 4Department of Infectious Diseases, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA
Abstract
Background: Salmonella aortitis is a rare, life-threatening infection historically associated with near-universal mortality without surgery. When surgery is not possible, the choice of oral agent, particularly when fluoroquinolones cannot be used, and the conduct of long-term suppression are guided by few reported cases.
Case: An 85-year-old man with diabetes mellitus, coronary artery disease, and atrial fibrillation presented in septic shock from Salmonella Enteritidis bacteremia with infrarenal aortitis. Bacteremia cleared by hospital day 2 on intravenous ceftriaxone. Because operative risk was prohibitive and the patient preferred non-operative care, a multidisciplinary team elected antibiotic therapy alone: six weeks of intravenous ceftriaxone followed by oral trimethoprim-sulfamethoxazole, chosen because the isolate was only intermediately susceptible to ciprofloxacin (minimum inhibitory concentration 0.25 μg/mL). On serial computed tomography angiography, periaortic inflammation was unchanged through week 7 despite clinical improvement, improved at week 15, and resolved completely at approximately 9 months, with no aneurysm, pseudoaneurysm, or periaortic gas on any of eight studies. Inflammatory markers normalized during that time. After radiographic resolution, and with appetite and weight loss possibly related to trimethoprim-sulfamethoxazole, suppression was stepped down to reduced-dose oral amoxicillin, planned to continue for the foreseeable future.
Conclusion: Carefully selected patients with non-aneurysmal native Salmonella aortitis and prohibitive operative risk may achieve clinical and radiographic resolution with antibiotics alone, even when fluoroquinolones are not an option. This case illustrates susceptibility-guided selection of an oral agent and step-down to a better-tolerated agent after resolution. Radiographic response lagged clinical response by months; unchanged early imaging should not by itself be read as treatment failure.
Related
- P072 A case of Salmonella aortitis: a rare but important mimic of large vessel vasculitis that can be fatal if missed
- An Exploratory Study on the Antibiotic Potentiation Activity of Riboflavin Against Biofilm‐Forming Multidrug‐Resistant Salmonella and Shigella Clinical Isolates
- Phenotypic Antimicrobial Resistance Patterns in E. coli, Salmonella, and Enterobacter Species Isolated from Broiler Chicken Meat in Mzimba, Malawi: Insights from the Multiple Antibiotic Resistance Index.
- Palmoplantar Maculopapular Rash Mimicking Secondary Syphilis in Infectious Mononucleosis After Sequential Antibiotic Exposure: A Case Report
- LARGE: A large language model-based tool that unveils high-resolution temporal dynamics of the antibiotic resistome during human aging
BibTeX
@article{kim2026salmonella,
title = {{Salmonella aortitis without surgery or fluoroquinolones: Complete resolution with sequential antibiotic therapy}},
author = {Andrew Kim and Dinasha Navindi and Junho Kwon and Siddhanth Hegde and Wesley Lew and Allison Sarmiento and Nour Khouzam},
journal = {IDCases},
year = {2026},
month = oct,
doi = {10.1016/j.idcr.2026.e02815},
url = {https://doi.org/10.1016/j.idcr.2026.e02815},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Salmonella aortitis without surgery or fluoroquinolones: Complete resolution with sequential antibiotic therapy
AU - Andrew Kim
AU - Dinasha Navindi
AU - Junho Kwon
AU - Siddhanth Hegde
AU - Wesley Lew
AU - Allison Sarmiento
AU - Nour Khouzam
PY - 2026
DA - 2026/10/23
JO - IDCases
DO - 10.1016/j.idcr.2026.e02815
UR - https://doi.org/10.1016/j.idcr.2026.e02815
AB - Background: Salmonella aortitis is a rare, life-threatening infection historically associated with near-universal mortality without surgery. When surgery is not possible, the choice of oral agent, particularly when fluoroquinolones cannot be used, and the conduct of long-term suppression are guided by few reported cases. Case: An 85-year-old man with diabetes mellitus, coronary artery disease, and atrial fibrillation presented in septic shock from Salmonella Enteritidis bacteremia with infrarenal aortitis. Bacteremia cleared by hospital day 2 on intravenous ceftriaxone. Because operative risk was prohibitive and the patient preferred non-operative care, a multidisciplinary team elected antibiotic therapy alone: six weeks of intravenous ceftriaxone followed by oral trimethoprim-sulfamethoxazole, chosen because the isolate was only intermediately susceptible to ciprofloxacin (minimum inhibitory concentration 0.25 μg/mL). On serial computed tomography angiography, periaortic inflammation was unchanged through week 7 despite clinical improvement, improved at week 15, and resolved completely at approximately 9 months, with no aneurysm, pseudoaneurysm, or periaortic gas on any of eight studies. Inflammatory markers normalized during that time. After radiographic resolution, and with appetite and weight loss possibly related to trimethoprim-sulfamethoxazole, suppression was stepped down to reduced-dose oral amoxicillin, planned to continue for the foreseeable future. Conclusion: Carefully selected patients with non-aneurysmal native Salmonella aortitis and prohibitive operative risk may achieve clinical and radiographic resolution with antibiotics alone, even when fluoroquinolones are not an option. This case illustrates susceptibility-guided selection of an oral agent and step-down to a better-tolerated agent after resolution. Radiographic response lagged clinical response by months; unchanged early imaging should not by itself be read as treatment failure.
SN - 2214-2509
ER -